Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
Marios K GeorgakisParaskevi PapathomaAnton RyzhovSnezana Zivkovic-PerisicSultan EserŁukasz TaraszkiewiczMario SekerijaTina ŽagarLuis AntunesAnna ZborovskayaJoana BastosMargareta FloreaDaniela CozaAnna DemetriouDomenic AgiusRajko M StrahinjaMarios ThemistocleousMaria ToliaSpyridon TzanisGeorge A AlexiouPanagiotis G PapanikolaouPanagiotis NomikosMaria KantzanouNick DessyprisApostolos PourtsidisEleni Th PetridouPublished in: Cancer (2017)
Despite definite survival gains over the last years, the considerable outcome disparities between the less affluent SEE region and the United States for AYAs with malignant CNS tumors point to health care delivery inequalities. No considerable prognostic deficits for CNS tumors are evident for AYAs versus children. Cancer 2017;123:4458-71. © 2017 American Cancer Society.